✦ LIBER ✦

Phase II trial of ifosfamide and cis-platinum in advanced or recurrent squamous carcinoma of the cervix: Preliminary report

✍ Scribed by M. Rodriguez; K. Look; M. Callagan; G. Sutton

Book ID: 119054339
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 161 KB
Volume: 45
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(92)90612-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

Phase II trial of ifosfamide and mesna in chemotherapy-naive patients with recurrent or advanced squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; W. McGuire; T. Patton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II trial of vinblastine in patient

Phase II trial of vinblastine in patients with advanced or recurrent squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; D. Smith; W. Barnes 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Ifosfamide with mesna in squamous carcin

Ifosfamide with mesna in squamous carcinoma of the cervix: Phase II results in patients with advanced or recurrent disease

✍ E.V. Hannigan; T.V. Dinh; M.G. Doherty 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Cis-platinum in treatment of advanced or

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

✍ Tate Thigpen; Hugh Shingleton; Howard Homesley; Leo Lagasse; John Blessing 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 3 views

Phase II trial of cis-diamminedichloropl

Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma

✍ Dr. Kazuo Tamura; Yasuhiko Araki; Hiromichi Tateyama; Moritaka Maeda; Masashi Se 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

Advanced squamous cell carcinoma of the head and neck, lung, esophagus, and uterine cervix is still a challenging cancer to the medical practice. We have treated 23 such patients with a combination of cis-platinum, vincristine, and peplomycin. Cis-platinum was given at a dose of 60 mg/ m2 on day 1,

Phase II trial of capecitabine in recurr

Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix

✍ Alfred D. Jenkins; Lois M. Ramondetta; Charlotte Sun; Taren Johnston; Judith K. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB